NGN Capital is a New York City based venture capital firm. They invest in the healthcare and biotechnology companies including drug products, medical devices and healthcare services sectors. NGN Capital focuses their investments on companies they feel have the potential to achieve above average equity returns.
NGN Capital invests across maturity stages, from seed and early stage to later stage, and predominately in the United States and Europe. Their European office is in Heidelberg, Germany.
NGN Capital has invested in Exosome Diagnostics, Endosense, Small Bone Innovations, Artisan Pharma, Noxxon Pharma, Valtech Cardio, BeneChill, Aerovance, Cerapedics and Vivaldi Biosciences.
They exited their investments in Exosome Diagnostics, Small Bone Innovations, Noxxon Pharma, Santhera Pharmaceuticals, Endosense, BeneChill, Valtech Cardio and EKOS Corporation.
Timeline
Funded Companies
A company developing and commercializing cancer molecular diagnostics based isolation of exosomes from body fluids. Exosome Diagnostics was founded in 2008.
Cerapedics is a Westminster, Colorado-based healthcare company.
People
Alexander Cuomo
Chief Financial Officer
John R. Constantino
Managing General Partner
Kenneth J. Gorelick
Venture Partner
Kenneth S. Abramowitz
Managing General Partner
Peter Johann
Managing General Partner
William J. Gedale
Senior Advisor
